Atomwise Reviews, Running Projects, Clients & Founder Details

Atomwise is a pharmaceutical company that is using AI to discover drugs before they go through clinical trials. The company has recently expanded its Board of Directors and created a Scientific Advisory Board to strengthen its drug discovery and development expertise. This is a significant step for Atomwise as it focuses on its own internal pipeline.

Atomwise has created a deep learning technology called AtomNet®, which is used for structure-based drug discovery. The company is developing a pipeline of small-molecule drug candidates that are advancing into preclinical studies. AtomNet® has been able to discover more undruggable targets than any other AI drug discovery platform. The company is working with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from venture capital firms to support its mission to make better medicines, faster.

The world is in a critical time where there is a need for new and better medicines. Atomwise believes that by leveraging advancing technology and scientific breakthroughs, we can accelerate drug discovery. With new data, new algorithms, and new compute platforms, Atomwise is tackling over 600 unique disease targets. The company hopes to ultimately save one billion lives. If you are interested in joining Atomwise's mission, you can visit their website at www.atomwise.com/careers.